BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 19418620)

  • 1. Clinical condition of chronic inflammatory demyelinating polyneuropathy (CIDP).
    Phillips LH
    Muscle Nerve; 2009 Apr; 39(4):v-vii. PubMed ID: 19418620
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
    Lin CS; Krishnan AV; Park SB; Kiernan MC
    Arch Neurol; 2011 Jul; 68(7):862-9. PubMed ID: 21747028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of axonal function in patients with chronic inflammatory demyelinating polyneuropathy after intravenous immunoglobulin therapy.
    Hughes RA; Mills K
    Arch Neurol; 2011 Jul; 68(7):844-6. PubMed ID: 21747026
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathogenesis and treatment of CIDP].
    Sobue G
    Rinsho Shinkeigaku; 2005 Nov; 45(11):963-5. PubMed ID: 16447774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting treatment responses to IV immunoglobulins: can we already ask the genes?
    Lehmann HC; Kieseier BC
    Neurology; 2009 Oct; 73(17):1344-5. PubMed ID: 19776375
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic inflammatory demyelinating polyneuropathy and sarcoidosis: fortuitous association?].
    Ducray F; Costedoat-Chalumeau N; Bouhour F; Rousset H; Vial C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S85-9. PubMed ID: 18087235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
    Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue as the presenting symptom of chronic inflammatory demyelinating polyneuropathy.
    Bissay V; Flamez A; Schmedding E; Ebinger G
    Muscle Nerve; 2008 Dec; 38(6):1653-7. PubMed ID: 19012289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual patients who experienced both Guillain-BarrĂ© syndrome and CIDP.
    Kuitwaard K; van der Pol WL; Ruts L; van Doorn PA
    J Peripher Nerv Syst; 2009 Mar; 14(1):66-8. PubMed ID: 19335542
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic inflammatory demyelinating polyradiculoneuropathy].
    Franques J; Azulay JP; Pouget J; Attarian S
    Rev Med Interne; 2010 Jun; 31(6):411-6. PubMed ID: 20395023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.
    Hughes RA
    Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
    Vina ER; Fang AJ; Wallace DJ; Weisman MH
    Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy.
    Lee DH; Linker RA; Paulus W; Schneider-Gold C; Chan A; Gold R
    Muscle Nerve; 2008 Mar; 37(3):406-9. PubMed ID: 17918749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of subcutaneous immunoglobulin administration in chronic inflammatory demyelinating polyneuropathy responders to intravenous immunoglobulin.
    Cocito D; Serra G; Falcone Y; Paolasso I
    J Peripher Nerv Syst; 2011 Jun; 16(2):150-2. PubMed ID: 21692916
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical childhood chronic inflammatory demyelinating polyneuropathy.
    Mohamed AR; Rodriguez-Casero MV; Ryan MM
    Muscle Nerve; 2010 Aug; 42(2):293-5. PubMed ID: 20589891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic strategy for chronic inflammatory demyelinating polyradiculoneuropathy. Recommendations of the French working group].
    Magy L;
    Rev Neurol (Paris); 2008 Dec; 164(12):1063-7. PubMed ID: 18950823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
    Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
    Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune therapy for chronic inflammatory demyelinating polyneuropathy: from clinical trials to real-life.
    Rajabally YA
    Eur J Neurol; 2010 Feb; 17(2):171-2. PubMed ID: 19845752
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
    Uzenot D; Azulay JP; Pouget J
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inflammatory demyelinating polyneuropathy associated with neurosyphilis.
    Kararizou E; Anagnostou E; Kapaki E; Davaki P
    Am J Med Sci; 2015 Jan; 349(1):90-1. PubMed ID: 25470500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.